John Lo is the Chief Commercial Officer at Beam Therapeutics, where they build commercial readiness and shape product and portfolio strategies for gene editing therapies. With a PhD in Biochemistry and Molecular Biology from the Massachusetts Institute of Technology, Lo has a strong foundation in science and a successful track record in strategic and commercial leadership across the biotechnology sector. They have held significant roles at several leading companies including Bristol-Myers Squibb and Celgene, where they advanced numerous product launches and portfolio strategies. Currently, as a Strategic Advisor at Erasca, they contribute to developing treatments for Ras-mutated cancers.
This person is not in the org chart
This person is not in any teams
This person is not in any offices